Evidence map›Paper›PMID 41852243›Full record

ArticleHistopathology2026

The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology.

Ian A Cree, Mark J Arends, Joseph D Khoury, Erika Re Denton, Anthony J Gill, Alexander J Lazar, Ian M Frayling, Stefan M Pfister, Mark A Rubin, Katia Rm Leite and 9 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Histopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ian A CreeInternational Agency for Research on Cancer, Lyon Cedex, France.ORCID https://orcid.org/0000-0001-5007-9456
Mark J ArendsCancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0002-6826-8770
Joseph D KhouryDepartment of Pathology, Microbiology, and Immunology, 985900 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NB, USA.ORCID https://orcid.org/0000-0003-2621-3584
Erika Re DentonNorfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.ORCID https://orcid.org/0000-0001-8650-862X
Anthony J GillDepartment of Anatomical Pathology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.ORCID https://orcid.org/0000-0002-9447-1967
Alexander J LazarUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-6395-4499
Ian M FraylingInherited Tumour Syndromes Research Group, School of Medicine, Cardiff University, Cardiff, UK.
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Mark A RubinUniversität Bern, Bern, Switzerland.
Katia Rm LeiteUniversity of São Paulo Medical School, São Paulo, SP, Brazil.ORCID https://orcid.org/0000-0002-2615-7730
Raymond DalgleishDivision of Genetics and Genome Biology, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0001-7667-187X
Elspeth A BrufordSchool of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-8380-5247
Sharon PlonBaylor College of Medicine, Houston, TX, USA.ORCID https://orcid.org/0000-0002-9626-0936
Ada HamoshDepartment of Genetic Medicine (DGM), McKusick-Nathans Institute, Johns Hopkins University, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-1780-5230
Michael Francis WalshMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Gabrielle Goldman-LévyInternational Agency for Research on Cancer, Lyon Cedex, France.ORCID https://orcid.org/0000-0002-8289-126X
Harshima WijesingheInternational Agency for Research on Cancer, Lyon Cedex, France.ORCID https://orcid.org/0000-0002-2847-1440
William D FoulkesDepartment of Human Genetics, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0000-0001-7427-4651
Dilani LokuhettyInternational Agency for Research on Cancer, Lyon Cedex, France.ORCID https://orcid.org/0000-0002-4275-3436

Funding

The Nomenclature of Human and Vertebrate GenesU24HG003345 · NHGRI · UNIVERSITY OF CAMBRIDGE · PI Elspeth Bruford · 2018 to 2026
$3.9M
NHGRI NIH HHS U24 HG003345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41852243
PMCPMC13333082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.